{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:55:24Z","timestamp":1774634124141,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012401","name":"Beijing Science and Technology Planning Project","doi-asserted-by":"publisher","award":["Z191100006619111"],"award-info":[{"award-number":["Z191100006619111"]}],"id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871290"],"award-info":[{"award-number":["81871290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8223000963"],"award-info":[{"award-number":["8223000963"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Peking University People\u2019s Hospital Research and Development Funds","award":["RS2022-04"],"award-info":[{"award-number":["RS2022-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10067-024-07262-2","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T14:30:05Z","timestamp":1737729005000},"page":"969-978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical features of inflammatory arthritis in daily practice\u2014China\u2019s perspective"],"prefix":"10.1007","volume":"44","author":[{"given":"Wenwen","family":"Pei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranran","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxue","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqiu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shufei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5444-3435","authenticated-orcid":false,"given":"Yin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"issue":"10","key":"7262_CR1","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41584-023-01009-0","volume":"19","author":"MM Jeljeli","year":"2023","unstructured":"Jeljeli MM, Adamopoulos IE (2023) Innate immune memory in inflammatory arthritis. Nat Rev Rheumatol 19(10):627\u2013639. https:\/\/doi.org\/10.1038\/s41584-023-01009-0","journal-title":"Nat Rev Rheumatol"},{"issue":"21","key":"7262_CR2","doi-asserted-by":"publisher","first-page":"8125","DOI":"10.3390\/ijms21218125","volume":"21","author":"CH Tang","year":"2020","unstructured":"Tang CH (2020) Research of Pathogenesis and Novel Therapeutics in Arthritis 2.0. Int J Mol Sci 21(21):8125. https:\/\/doi.org\/10.3390\/ijms21218125","journal-title":"Int J Mol Sci"},{"issue":"4","key":"7262_CR3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/rheumatology\/ker370","volume":"51","author":"R Li","year":"2012","unstructured":"Li R, Sun J, Ren LM, Wang HY et al (2012) Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology 51(4):721\u2013729. https:\/\/doi.org\/10.1093\/rheumatology\/ker370","journal-title":"Rheumatology"},{"issue":"24","key":"7262_CR4","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1097\/CM9.0000000000000570","volume":"132","author":"C Li","year":"2019","unstructured":"Li C, Zhang Y, Song H et al (2019) Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis. Chin Med J 132(24):2899\u20132904. https:\/\/doi.org\/10.1097\/CM9.0000000000000570","journal-title":"Chin Med J"},{"issue":"9","key":"7262_CR5","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/annrheumdis-2012-203165","volume":"72","author":"KV Wevers-de Boer","year":"2013","unstructured":"Wevers-de Boer KV, Heimans L, Huizinga TW, Allaart CF (2013) Drug therapy in undifferentiated arthritis: a systematic literature review. Ann Rheum Dis 72(9):1436\u20131444. https:\/\/doi.org\/10.1136\/annrheumdis-2012-203165","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"7262_CR6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.7326\/0003-4819-136-12-200206180-00011","volume":"136","author":"MA Khan","year":"2002","unstructured":"Khan MA (2002) Update on spondyloarthropathies. Ann Intern Med 136(12):896\u2013907. https:\/\/doi.org\/10.7326\/0003-4819-136-12-200206180-00011","journal-title":"Ann Intern Med"},{"issue":"1","key":"7262_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","volume":"7","author":"O FitzGerald","year":"2021","unstructured":"FitzGerald O, Ogdie A, Chandran V et al (2021) Psoriatic arthritis. Nat Rev Dis Prim 7(1):59. https:\/\/doi.org\/10.1038\/s41572-021-00293-y","journal-title":"Nat Rev Dis Prim"},{"issue":"2","key":"7262_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jaad.2015.05.001","volume":"73","author":"AP Villani","year":"2015","unstructured":"Villani AP, Rouzaud M, Sevrain M et al (2015) Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol 73(2):242\u2013248. https:\/\/doi.org\/10.1016\/j.jaad.2015.05.001","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"7262_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","volume":"53","author":"LE Dean","year":"2014","unstructured":"Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, Macfarlane GJ (2014) Global prevalence of ankylosing spondylitis. Rheumatology (Oxford) 53(4):650\u2013657. https:\/\/doi.org\/10.1093\/rheumatology\/ket387","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"7262_CR10","doi-asserted-by":"publisher","first-page":"101723","DOI":"10.1016\/j.berh.2021.101723","volume":"35","author":"A Danve","year":"2021","unstructured":"Danve A, Sehra ST, Neogi T (2021) Role of diet in hyperuricemia and gout. Best Pract Res Clin Rheumatol 35(4):101723. https:\/\/doi.org\/10.1016\/j.berh.2021.101723","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"7262_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","volume":"5","author":"N Dalbeth","year":"2019","unstructured":"Dalbeth N, Choi HK, Joosten LAB et al (2019) Stamp LK. Gout Nat Rev Dis Primers 5(1):69. https:\/\/doi.org\/10.1038\/s41572-019-0115-y","journal-title":"Gout Nat Rev Dis Primers"},{"issue":"3","key":"7262_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/art.39465","volume":"68","author":"X Tang","year":"2016","unstructured":"Tang X, Wang S, Zhan S et al (2016) The prevalence of symptomatic knee osteoarthritis in China: results from the china health and retirement longitudinal study. Arthritis Rheumatol 68(3):648\u2013653. https:\/\/doi.org\/10.1002\/art.39465","journal-title":"Arthritis Rheumatol"},{"key":"7262_CR13","doi-asserted-by":"publisher","first-page":"101981","DOI":"10.1016\/j.arr.2023.101981","volume":"89","author":"W Li","year":"2023","unstructured":"Li W, Yu L, Li W et al (2023) Prevention and treatment of inflammatory arthritis with traditional Chinese medicine: Underlying mechanisms based on cell and molecular targets. Ageing Res Rev 89:101981. https:\/\/doi.org\/10.1016\/j.arr.2023.101981","journal-title":"Ageing Res Rev"},{"key":"7262_CR14","doi-asserted-by":"publisher","first-page":"800902","DOI":"10.3389\/fimmu.2022.800902","volume":"13","author":"Y Huang","year":"2022","unstructured":"Huang Y, Liu Y, Huang Q et al (2022) TMT-based quantitative proteomics analysis of synovial fluid-derived exosomes in inflammatory arthritis. Front Immunol 13:800902. https:\/\/doi.org\/10.3389\/fimmu.2022.800902","journal-title":"Front Immunol"},{"issue":"11","key":"7262_CR15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41584-018-0073-x","volume":"14","author":"F Berenbaum","year":"2018","unstructured":"Berenbaum F, Wallace IJ, Lieberman DE, Felson DT (2018) Modern-day environmental factors in the pathogenesis of osteoarthritis. Nat Rev Rheumatol 14(11):674\u2013681. https:\/\/doi.org\/10.1038\/s41584-018-0073-x","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"7262_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41584-021-00747-3","volume":"18","author":"M Favero","year":"2022","unstructured":"Favero M, Belluzzi E, Ortolan A et al (2022) Erosive hand osteoarthritis: latest findings and outlook. Nat Rev Rheumatol 18(3):171\u2013183. https:\/\/doi.org\/10.1038\/s41584-021-00747-3","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"7262_CR17","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.219","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheu72m 54(8):2665\u201373. https:\/\/doi.org\/10.1002\/art.219","journal-title":"Arthritis Rheu72m"},{"key":"7262_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324. https:\/\/doi.org\/10.1002\/art.1780310302","journal-title":"Arthritis Rheum"},{"issue":"4","key":"7262_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361\u20138. https:\/\/doi.org\/10.1002\/art.1780270401","journal-title":"Arthritis Rheum"},{"issue":"2","key":"7262_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/art.41142","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski SL, Neogi T, Hochberg MC et al (2020) 2019 American College of rheumatology\/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol 72(2):220\u2013233. https:\/\/doi.org\/10.1002\/art.41142","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"7262_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","volume":"79","author":"P Richette","year":"2020","unstructured":"Richette P, Doherty M, Pascual E et al (2020Jan) (2020) 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis 79(1):31\u201338. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215315","journal-title":"Ann Rheum Dis"},{"issue":"14","key":"7262_CR22","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.3390\/jcm10143006","volume":"10","author":"E Favoino","year":"2021","unstructured":"Favoino E, Urso L, Serafino A et al (2021) HLA allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and\/or arthritis not fulfilling ASAS criteria: comparison with psoriatic and undifferentiated spondyloarthritis. J Clin Med 10(14):3006. https:\/\/doi.org\/10.3390\/jcm10143006","journal-title":"J Clin Med"},{"issue":"8","key":"7262_CR23","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1093\/rheumatology\/keac127","volume":"61","author":"S Pazmino","year":"2022","unstructured":"Pazmino S, Westhovens R, Doumen M, Bertrand D, Verschueren P (2022) Undifferentiated arthritis, not just another early manifestation of rheumatoid arthritis. Rheumatology 61(8):3101\u20133103. https:\/\/doi.org\/10.1093\/rheumatology\/keac127","journal-title":"Rheumatology"},{"key":"7262_CR24","unstructured":"Braun J, Kingsley G, van der Heijde D, Sieper J (2000) On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3\u20136, 1999. J Rheumatol 27(9):2185\u201392"},{"issue":"3","key":"7262_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","volume":"10","author":"M Harbord","year":"2016","unstructured":"Harbord M, Annese V, Vavricka SR et al (2016) The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis 10(3):239\u2013254. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv213","journal-title":"J Crohns Colitis"},{"issue":"5","key":"7262_CR26","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1093\/rheumatology\/keab651","volume":"61","author":"DI Krijbolder","year":"2022","unstructured":"Krijbolder DI, Wouters F, van Mulligen E, van der Helm-van Mil AHM (2022) Morning stiffness precedes the development of rheumatoid arthritis and associates with systemic and subclinical joint inflammation in arthralgia patients. Rheumatology 61(5):2113\u20132118. https:\/\/doi.org\/10.1093\/rheumatology\/keab651","journal-title":"Rheumatology"},{"issue":"2","key":"7262_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/BOR.0000000000000479","volume":"30","author":"ER Vina","year":"2018","unstructured":"Vina ER, Kwoh CK (2018) Epidemiology of osteoarthritis: literature update. Curr Opin Rheumatol 30(2):160\u2013167. https:\/\/doi.org\/10.1097\/BOR.0000000000000479","journal-title":"Curr Opin Rheumatol"},{"issue":"10055","key":"7262_CR28","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023\u20132038. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"issue":"5","key":"7262_CR29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3899\/jrheum.140808","volume":"42","author":"S Wu","year":"2015","unstructured":"Wu S, Cho E, Li WQ, Han J, Qureshi AA (2015) Alcohol intake and risk of incident psoriatic arthritis in women. J Rheumatol 42(5):835\u2013840. https:\/\/doi.org\/10.3899\/jrheum.140808","journal-title":"J Rheumatol"},{"issue":"24","key":"7262_CR30","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1136\/bjsports-2022-105626","volume":"56","author":"SR Filbay","year":"2022","unstructured":"Filbay SR, Skou ST, Bullock GS et al (2022) Long-term quality of life, work limitation, physical activity, economic cost and disease burden following ACL and meniscal injury: a systematic review and meta-analysis for the OPTIKNEE consensus. Br J Sports Med 56(24):1465\u20131474. https:\/\/doi.org\/10.1136\/bjsports-2022-105626","journal-title":"Br J Sports Med"},{"issue":"7","key":"7262_CR31","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.3390\/jcm12072622","volume":"12","author":"E \u017belnio","year":"2023","unstructured":"\u017belnio E, Taljanovic M, Ma\u0144czak M, Sudo\u0142-Szopi\u0144ska I (2023) Hand and wrist involvement in seropositive rheumatoid arthritis, seronegative rheumatoid arthritis, and psoriatic arthritis-the value of classic radiography. J Clin Med 12(7):2622. https:\/\/doi.org\/10.3390\/jcm12072622","journal-title":"J Clin Med"},{"issue":"11","key":"7262_CR32","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s11547-019-01001-3","volume":"124","author":"F Salaffi","year":"2019","unstructured":"Salaffi F, Carotti M, Beci G, Di Carlo M, Giovagnoni A (2019) Radiographic scoring methods in rheumatoid arthritis and psoriatic arthritis. Radiol Med 124(11):1071\u20131086. https:\/\/doi.org\/10.1007\/s11547-019-01001-3","journal-title":"Radiol Med"},{"issue":"7","key":"7262_CR33","first-page":"1511","volume":"28","author":"EJ Kroot","year":"2001","unstructured":"Kroot EJ, van Gestel AM, Swinkels HL et al (2001) Chronic comorbidity in patients with early rheumatoid arthritis: a descriptive study. J Rheumatol 28(7):1511\u20131517","journal-title":"J Rheumatol"},{"issue":"12","key":"7262_CR34","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.3899\/jrheum.150166","volume":"42","author":"FA Pinheiro","year":"2015","unstructured":"Pinheiro FA, Souza DC, Sato EI (2015) A study of multiple causes of death in rheumatoid arthritis. J Rheumatol 42(12):2221\u20132228. https:\/\/doi.org\/10.3899\/jrheum.150166","journal-title":"J Rheumatol"},{"issue":"4","key":"7262_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A (2021) Rheumatoid arthritis: Extra-articular manifestations and comorbidities. Autoimmun Rev 20(4):102776. https:\/\/doi.org\/10.1016\/j.autrev.2021.102776","journal-title":"Autoimmun Rev"},{"issue":"4","key":"7262_CR36","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/art.20967","volume":"52","author":"CE Antoni","year":"2005","unstructured":"Antoni CE, Kavanaugh A, Kirkham B et al (2005) Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Arthritis Rheum 52(4):1227\u20131236. https:\/\/doi.org\/10.1002\/art.20967","journal-title":"Arthritis Rheum"},{"issue":"1","key":"7262_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/annrheumdis-2019-215386","volume":"79","author":"PJ Mease","year":"2020","unstructured":"Mease PJ, Smolen JS, Behrens F et al (2020) A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-na\u00efve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. Ann Rheum Dis 79(1):123\u2013131. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215386","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7262_CR38","doi-asserted-by":"publisher","first-page":"e001838","DOI":"10.1136\/rmdopen-2021-001838","volume":"7","author":"IB McInnes","year":"2021","unstructured":"McInnes IB, Kato K, Magrey M et al (2021) Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study. RMD Open 7(3):e001838. https:\/\/doi.org\/10.1136\/rmdopen-2021-001838","journal-title":"RMD Open"},{"issue":"3","key":"7262_CR39","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/annrheumdis-2020-218870","volume":"80","author":"PJ Mease","year":"2021","unstructured":"Mease PJ, Lertratanakul A, Anderson JK et al (2021) Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2. Ann Rheum Dis 80(3):312\u2013320. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218870","journal-title":"Ann Rheum Dis"},{"key":"7262_CR40","doi-asserted-by":"publisher","first-page":"CD005468","DOI":"10.1002\/14651858.CD005468.pub2","volume":"4","author":"LJ Maxwell","year":"2015","unstructured":"Maxwell LJ, Zochling J, Boonen A et al (2015) TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev 4:CD005468. https:\/\/doi.org\/10.1002\/14651858.CD005468.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"10093","key":"7262_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0140-6736(17)31618-5","volume":"390","author":"R Fleischmann","year":"2017","unstructured":"Fleischmann R, Mysler E, Hall S et al (2017) Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b\/4, double-blind, head-to-head, randomised controlled trial. Lancet 390(10093):457\u2013468. https:\/\/doi.org\/10.1016\/S0140-6736(17)31618-5","journal-title":"Lancet"},{"issue":"9","key":"7262_CR42","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1177\/1060028019839650","volume":"53","author":"A Mogul","year":"2019","unstructured":"Mogul A, Corsi K, McAuliffe L (2019) Baricitinib: The Second FDA-Approved JAK Inhibitor for the Treatment of Rheumatoid Arthritis. Ann Pharmacother 53(9):947\u2013953. https:\/\/doi.org\/10.1177\/1060028019839650","journal-title":"Ann Pharmacother"},{"issue":"11","key":"7262_CR43","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/art.41032","volume":"71","author":"R Fleischmann","year":"2019","unstructured":"Fleischmann R, Pangan AL, Song IH et al (2019) Upadacitinib versus placebo or adalimumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase iii, double-blind randomized controlled trial. Arthritis Rheumatol 71(11):1788\u20131800. https:\/\/doi.org\/10.1002\/art.41032","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"7262_CR44","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/annrheumdis-2022-222586","volume":"81","author":"K Lauper","year":"2022","unstructured":"Lauper K, Iudici M, Mongin D et al (2022) Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the \u201cJAK-pot\u201d collaboration. Ann Rheum Dis 81(10):1358\u20131366. https:\/\/doi.org\/10.1136\/annrheumdis-2022-222586","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07262-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07262-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07262-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T08:18:25Z","timestamp":1740557905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07262-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["7262"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07262-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by the Research Ethics Committee at Peking University People\u2019s Hospital, Beijing, China (approval No.2020PHB021-01). All patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"During the preparation of this work, the authors did not use any AI tools.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}